Masked Hypertension
Conditions
Keywords
clinical trials, Gastrodia and Uncaria Drink
Brief summary
The purpose of this study is 1. To determine whether the Gastrodia and Uncaria Drink is effective in the treatment of masked hypertensive patients below 70 years. 2. To find out the suitable groups for the Gastrodia and Uncaria Drink treatment.
Interventions
DRUGGastrodia and Uncaria Drink
Gastrodia and Uncaria Drink, 1 dose at a time, twice a day, duration: 4 weeks
Sponsors
Shanghai Institute of Hypertension
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* age between 18 to 70 years * didn't use any anti-hypertension drugs within 2 weeks * stage 1 masked hypertensive patients, which means clinic blood pressure\<140/90 mmHg,however the daytime(8:00-18:00) 24h ambulatory blood pressure between 135/85 and 150/95mmHg * be willing to participate in the trials and able to finish clinic visit
Exclusion criteria
* secondary hypertension * be allergic to the clinical trial medicine * occurrence of stroke, CKD, myocardial infarction within 2 years * dysfunction of liver or kidney and fundus hemorrhage * arrhythmia * ALT, AST, TBL upper the twice of normal range, Scr≥2.0mg/dl, K+≥5.5mmol/L, Urine protein≥2+ * psychiatric disorders * pregnant, breastfeeding * other serious conditions in which is not fit for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood pressure | March 1,2015 |
Countries
China
Contacts
Primary ContactYan Li, doctor
Outcome results
None listed